Efficacy of Tenofovir in Patients with Lamivudine Failure Is Not Different from That in Nucleoside/Nucleotide Analogue-Naïve Patients with Chronic Hepatitis B

We evaluated the efficacy of tenofovir disoproxil fumarate (TDF) in patients with lamivudine failure (LAM-F) in comparison with that in nucleoside/nucleotide analogue (NA)-naïve patients with chronic hepatitis B (CHB). The criteria for inclusion were being NA naïve or having previous LAM-F and recei...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Baran, Bulent, Soyer, Ozlem Mutluay, Ormeci, Asli Cifcibasi, Gokturk, Suut, Evirgen, Sami, Bozbey, Hamza Ugur, Akyuz, Filiz, Karaca, Cetin, Demir, Kadir, Besisik, Fatih, Onel, Derya, Gulluoglu, Mine, Badur, Selim, Kaymakoglu, Sabahattin
Format: Artigo
Langue:Inglês
Publié: American Society for Microbiology 2013
Sujets:
Antiviral Agents
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3623318/
https://ncbi.nlm.nih.gov/pubmed/23380725
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02600-12
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires